- Home
- UGI vs QGEN Comparison
UGI vs QGEN Comparison
Compare UGI & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UGI | QGEN |
|---|---|---|
| Founded | 1940 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5B | 8.7B |
| IPO Year | 1994 | 1998 |
Fundamental Metrics
Financial Performance| Metric | UGI | QGEN |
|---|---|---|
| Price | $35.40 | $42.94 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 8 |
| Target Price | $44.00 | ★ $45.76 |
| AVG Volume (30 Days) | 1.4M | ★ 2.4M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | 3.99% | ★ 7.17% |
| EPS Growth | ★ 147.20 | N/A |
| EPS | ★ 3.08 | N/A |
| Revenue | ★ $7,287,000,000.00 | N/A |
| Revenue This Year | $8.88 | $8.18 |
| Revenue Next Year | $2.27 | $5.71 |
| P/E Ratio | ★ $11.45 | $24.01 |
| Revenue Growth | ★ 1.07 | N/A |
| 52 Week Low | $31.62 | $32.53 |
| 52 Week High | $41.34 | $57.82 |
Technical Indicators
Market Signals| Indicator | UGI | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 47.63 | 58.85 |
| Support Level | $33.45 | $42.82 |
| Resistance Level | $35.80 | $44.03 |
| Average True Range (ATR) | 0.78 | 0.87 |
| MACD | -0.13 | -0.01 |
| Stochastic Oscillator | 44.66 | 55.93 |
Price Performance
Historical ComparisonAbout UGI UGI Corporation
UGI Corp is an American holding company that, through its subsidiaries, is involved in the transport and marketing of energy and related services. Its segments include AmeriGas Propane, UGI International, Midstream & Marketing, and Utilities. The AmeriGas Propane segment consists of the propane distribution business. The UGI International segment consists of LPG distribution businesses. The Midstream & Marketing segment consists of energy-related businesses. The Utilities segment consists of the regulated natural gas and electric distribution. The company derives a majority of its revenue from the UGI International segment.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).